Pfizer (PFE) is close to a $7.3B takeover of Metsera, planning to pay the company $47.50 per share in cash and an additional $22.50 if certain milestones are met, Oliver Barnes of The Financial Times reports, citing two people familiar with the matter. The acquisition could be announced as early as Monday, the sources added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- M&A News: Metsera Stock (MTSR) Rallies over 50% as Pfizer Nears $7.3B Takeover
- CDC panel votes against requiring prescriptions for Covid shots, Bloomberg says
- Pfizer, BioNTech express dedication to making safe Covid vaccines
- CDC panel votes to end universal Covid vaccine recommendation, Bloomberg says
- Mixed options sentiment in Pfizer with shares up 0.48%